ID   B901L
AC   CVCL_U098
DR   Cosmic; 1513406
DR   RCB; RCB3530
DR   Wikidata; Q54752916
RX   PubMed=11267941;
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=21498706;
CC   Population: Japanese.
CC   HLA typing: A*02:06,26:01; B*39:01,40:06; C*07:02,08:01 (PubMed=12114371).
CC   Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (PubMed=21498706).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
RX   PubMed=11267941; DOI=10.1111/j.1349-7006.2001.tb01096.x;
RA   Takenoyama M., Yoshino I., Eifuku R., So T., Imahayashi S., Sugaya M.,
RA   Yasuda M., Inoue M., Ichiyoshi Y., Osaki T., Nagashima A., Nomoto K.,
RA   Yasumoto K.;
RT   "Successful induction of tumor-specific cytotoxic T lymphocytes from
RT   patients with non-small cell lung cancer using CD80-transfected
RT   autologous tumor cells.";
RL   Jpn. J. Cancer Res. 92:309-315(2001).
//
RX   PubMed=12114371; DOI=10.1378/chest.122.1.282;
RA   Sugaya M., Takenoyama M., Osaki T., Yasuda M., Nagashima A., Sugio K.,
RA   Yasumoto K.;
RT   "Establishment of 15 cancer cell lines from patients with lung cancer
RT   and the potential tools for immunotherapy.";
RL   Chest 122:282-288(2002).
//
RX   PubMed=16651449; DOI=10.1158/0008-5472.CAN-05-3840;
RA   Fukuyama T., Hanagiri T., Takenoyama M., Ichiki Y., Mizukami M.,
RA   So T., Sugaya M., So T., Sugio K., Yasumoto K.;
RT   "Identification of a new cancer/germline gene, KK-LC-1, encoding an
RT   antigen recognized by autologous CTL induced on human lung
RT   adenocarcinoma.";
RL   Cancer Res. 66:4922-4928(2006).
//
RX   PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x;
RA   Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y.,
RA   Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K.,
RA   Yasumoto K.;
RT   "Cytokine production of lung cancer cell lines: correlation between
RT   their production and the inflammatory/immunological responses both in
RT   vivo and in vitro.";
RL   Cancer Sci. 98:1048-1054(2007).
//
RX   PubMed=17725806; DOI=10.1111/j.1349-7006.2007.00586.x;
RA   Baba T., Hanagiri T., Ichiki Y., Kuroda K., Shigematsu Y.,
RA   Mizukami M., Sugaya M., Takenoyama M., Sugio K., Yasumoto K.;
RT   "Lack and restoration of sensitivity of lung cancer cells to cellular
RT   attack with special reference to expression of human leukocyte
RT   antigen class I and/or major histocompatibility complex class I chain
RT   related molecules A/B.";
RL   Cancer Sci. 98:1795-1802(2007).
//
RX   PubMed=21498706;
RA   Onitsuka T., Uramoto H., Tanaka F.;
RT   "Lack of direct association between EGFR mutations and ER beta
RT   expression in lung cancer.";
RL   Anticancer Res. 31:855-860(2011).
//